Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- VIRP.PA
- Price
- 323.50
- Stock movement up
- +0.50 (0.15%)
- Company name
- Virbac SA
- Exchange
- (PA ,
- Currency
- EUR )
- Sector
- Healthcare >Drug Manufacturers - General
- Markedsværdi
- 2.71B
- Ent værdi
- 3.35B
- Pris/omsætning
- 1.39
- Pris/bog
- 2.72
- Udbytte afkast
- -
- Udbyttevækst
- -
- Vekst år
- -
- FCF-udbetaling
- 37.36%
- Efterfølgende P/E
- 12.54
- Fremtidig P/E
- 16.31
- PEG
- -
- EPS-vekst
- 43.21%
- 1 års afkast
- -3.43%
- 3 års afkast
- -4.33%
- 5 års afkast
- 10.95%
- 10 års afkast
- 3.83%
Senest opdateret: 2025-06-22
UDBYTTE
VIRP.PA betaler ikke udbytte
VÆRDIANSÆTTELSE
Værdiansættelsesforhold
Loading...
Værdiansættelsesforhold-data
| Efterfølgende P/E | 12.54 |
| Pris til OCF | 16.53 |
| Pris til FCF | 36.41 |
| Pris til EBITDA | 5.97 |
| EV i forhold til EBITDA | 7.39 |
Værdiansættelse (salg/bogført værdi)
Loading...
Værdiansættelse (salg/bogført værdi)-data
| Pris til omsætning | 1.39 |
| Pris til egenkapital | 2.72 |
| EV i forhold til salg | 1.72 |
ØKONOMI
Pr. aktie
Loading...
Data pr. aktie
| Aktuelt antal aktier | 8.37M |
| EPS (TTM) | 25.76 |
| FCF pr. aktie (TTM) | 8.88 |
Resultatopgørelse
Loading...
Resultatopgørelse-data
| Omsætning (TTM) | 1.95B |
| Bruttofortjeneste (TTM) | 1.10B |
| Driftsindkomst (TTM) | 319.79M |
| Nettoindkomst (TTM) | 215.97M |
| EPS (TTM) | 25.76 |
| EPS (1 år frem) | 19.83 |
Marginer
Loading...
Marginer-data
| Bruttomargin (TTM) | 56.53% |
| Driftsmargin (TTM) | 16.40% |
| Fortjenstmargin (TTM) | 11.08% |
Balance
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
| Kontanter | 156.86M |
| Nettotilgodehavender | 222.60M |
| Omsætningsaktiver i alt | 877.29M |
| Goodwill | 314.26M |
| Immaterielle aktiver | 185.15M |
| Ejendomme, anlæg og udstyr | 0.00 |
| Sum aktiver | 1.80B |
| Kreditor | 138.11M |
| Kortfristet/nuværende langsigtet gæld | 407.00M |
| Summen af kortfristede forpligtelser | 530.63M |
| Sum gæld | 801.99M |
| Aktionærernes egenkapital | 994.24M |
| Materielle nettoaktiver | 0.00 |
Likviditet
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
| Likviditet fra driften (TTM) | 163.94M |
| Investeringsudgifter (TTM) | 77.52M |
| Fri pengestrøm (TTM) | 74.41M |
| Udbetalt udbytte (TTM) | 27.80M |
Finansiel indkomst
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
| Egenkapitalafkast | 21.72% |
| Afkast af aktiver | 12.02% |
| Afkast af investeret kapital | 18.12% |
| Kontant afkast af investeret kapital | 6.24% |
INFORMATION OM AKTIER
Aktiediagram
Loading...
Aktiekurs-data
| Åbning | 323.50 |
| Daglig høj | 326.50 |
| Daglig lav | 321.00 |
| Daglig volumen | 8K |
| Højeste gennem alle tider | 443.00 |
| 1 års analytiker estimat | 402.94 |
| Beta | 0.97 |
| EPS (TTM) | 25.76 |
| Udbytte pr. aktie | - |
| Ex-div dato | 25 Jun 2024 |
| Næste dato for resultatpræsentation | 12 Sep 2025 |
Nedsidepotensial
Loading...
Nedsidepotensial-data
| VIRP.PA | S&P500 | |
| Nuværende prisfald fra top notering | -26.98% | -3.04% |
| Højeste prisfald | -62.10% | -56.47% |
| Højeste efterår dato | 13 Apr 1999 | 9 Mar 2009 |
| Gennemsnitlig fald fra toppen | -21.83% | -11.04% |
| Gennemsnitlig tid til nyt højdepunkt | 31 days | 12 days |
| Maks. tid til nyt højdepunkt | 2000 days | 1805 days |
OPLYSNINGER OM VIRKSOMHEDEN
Markedsværdi
2.71B
Markedsværdi kategori
Mid-cap
Beskrivelse
Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Personale
5459
Hjemmeside
Investor relationer
-
SEC-indsendelser
Adm. direktør
Land
France
By
Aktietype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
FORSTÅ FORRETNINGEN
Loading...
NYHEDER OM VIRKSOMHEDEN
Alle nyhederPressemeddelelser
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Pet Oral Care Products Market size & share revenue was valued at appr...
10. juli 2025
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the Fre...
4. juli 2025
The global pet dietary supplements market, valued at USD 2.71 billion in 2025, is projected to reach USD 4.11 billion by 2030, growing at a CAGR of 8.7%. This surge is fueled by pet owners seeking sup...
2. juli 2025
Virbac announces the appointment of Paul Martingell as the chief executive officer of the Virbac group, effective September 1, 2025. Paul Martingell, 45, is recognized as a leader who has demonstrated...
19. juni 2025
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the Fre...
10. juni 2025
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the Fre...
7. maj 2025
In the first quarter of 2025, revenue recorded solid growth of +4.9% at constant exchange rates and scope KEY FIGURESRevenue1st quarter 2025€375.2MGrowth at constant exchange rates and scope1+4.9% of ...
15. april 2025
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the Fre...
9. april 2025
Very strong revenues increase of 13.6% at constant exchange rates, driven by: dynamic organic growth (+7.5%) strategic contribution of our acquisitions (+6.1%) 2024 operating income2 at an all-time hi...
13. marts 2025
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the Fre...
7. marts 2025
Næste side